KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Current Leases (2019 - 2025)

Historic Current Leases for Biolife Solutions (BLFS) over the last 7 years, with Q3 2025 value amounting to $2.2 million.

  • Biolife Solutions' Current Leases fell 2187.95% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 2187.95%. This contributed to the annual value of $1.5 million for FY2024, which is 1749.61% up from last year.
  • Per Biolife Solutions' latest filing, its Current Leases stood at $2.2 million for Q3 2025, which was down 2187.95% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Current Leases ranged from a high of $2.9 million in Q2 2023 and a low of $1.3 million during Q4 2023
  • Its 5-year average for Current Leases is $2.4 million, with a median of $2.6 million in 2021.
  • Per our database at Business Quant, Biolife Solutions' Current Leases soared by 26323.73% in 2021 and then crashed by 5503.5% in 2023.
  • Biolife Solutions' Current Leases (Quarter) stood at $2.8 million in 2021, then rose by 3.7% to $2.9 million in 2022, then crashed by 55.03% to $1.3 million in 2023, then increased by 17.5% to $1.5 million in 2024, then surged by 44.14% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.2 million for Q2 2025, and $1.8 million during Q1 2025.